Fagron, the leading global player in pharmaceutical compounding, is pleased to announce two strategic acquisitions that further strengthen its global footprint and diversify its capabilities. These ...
Fagron, the leading global player in pharmaceutical compounding, has acquired from Fresenius Kabi a 503B outsourcing facility in Boston. The transaction covers all operational aspects of the facility, ...
MIAMI--(BUSINESS WIRE)--Fagron North America, a leading supplier of compounded medications to hospital pharmacies and patients, will open one of the largest 503B human drug outsourcing facilities in ...
Nazareth (Belgium)/Rotterdam (The Netherlands), 12 January 2026 - 7:00 AM CET Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America Fagron, the leading ...
Fagron, the leading global player in pharmaceutical compounding, has announced a strategic acquisition of the University Compounding Pharmacy (UCP) in North America and the US FDA inspection update ...
Nazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 - 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Fagron, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results